Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve Audited financial results for the ....
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs has informed the stock exchanges that its Board of Directors will meet on Tuesday, February 3, 2026. The agenda includes considering and approving the audited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025. The Board will also consider declaring an interim dividend for FY 2025-26, if any. The trading window for the stock is already closed and will remain shut until 48 hours after the results are declared.
This is a routine pre-results intimation with no actual numbers disclosed yet. Investors should watch for the Q3 results and any dividend announcement on February 3, as both could drive short-term stock movement.